Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Nicola Silvestris et al.|The Oncologist|2017Cited by 35
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Mario Uccello et al.|The Oncologist|2018Cited by 8
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experienceE.S. Lutrino, Saverio Cinieri, Laura Orlando et al.|Tumori Journal|2019Cited by 6
Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experienceE.S. Lutrino, Saverio Cinieri, Laura Orlando et al.|Annals of Oncology|2016Cited by 1
Safety of Eribulin plus Trastuzumab in pre-treated HER2-positive advanced breast cancer (ABC) patients: results from an Italian observational studyLaura Orlando, Saverio Cinieri, E.S. Lutrino et al.|Annals of Oncology|2016Cited by 0